Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/60322
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/60322
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

PHILIP MEASE

Listed Specialty: Rheumatology
1101 MADISON ST STE 1000, SEATTLE, WA, 98104-3556

2018 Payments: At a Glance

434

payments

$374,488

payment total

30

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
 98 $174K
Consulting
 41 $161K
Travel and Lodging
 58 $30,734
Food and Beverage
 230 $7,538
Honoraria
 1 $990
Education
 6 $115

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
XELJANZ

drug

 $85,419
TALTZ

drug

 $77,318
COSENTYX

drug

 $61,031
Payments with no listed product

N/A

 $58,962
AIN457F

drug

 $41,124
SIMPONI ARIA

drug

 $13,634
CELEBREX

drug

 $7,475
STELARA

drug

 $7,145
AIN457A

drug

 $4,529
OTEZLA

drug

 $4,301
RENFLEXIS

drug

 $4,184
ORENCIA

drug

 $3,797
HUMIRA

drug

 $3,554
ACTEMRA

drug

 $2,735
CIMZIA

drug

 $2,680
KEVZARA

drug

 $1,714
ENBREL

drug

 $1,067
DIOVAN

drug

 $418
TYMLOS

drug

 $199
RAYOS

drug

 $131
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/60322

Payment Details

When How Much Related To What For From Third Party Payee
Oct 30, 2018 $10,031 AIN457F Consulting NOVARTIS PHARMA AG
Jan 1, 2018 $9,500 XELJANZ Consulting PFIZER INC.
Jan 29, 2018 $8,867 AIN457F Consulting NOVARTIS PHARMA AG
May 4, 2018 $7,800 No Listed Product Consulting ELI LILLY AND COMPANY
Oct 7, 2018 $7,601 AIN457F Travel and Lodging NOVARTIS PHARMA AG
Sep 22, 2018 $7,517 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Jan 5, 2018 $7,479 COSENTYX Consulting NOVARTIS PHARMA AG
Oct 15, 2018 $7,475 CELEBREX Consulting PFIZER INC.
Jan 8, 2018 $7,350 No Listed Product Consulting E.R. SQUIBB & SONS, L.L.C.
May 1, 2018 $7,200 TALTZ Consulting ELI LILLY AND COMPANY
May 1, 2018 $6,490 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Sep 11, 2018 $6,300 No Listed Product Consulting E.R. SQUIBB & SONS, L.L.C.
Mar 26, 2018 $6,165 AIN457F Consulting NOVARTIS PHARMA AG
Apr 6, 2018 $6,000 XELJANZ Consulting PFIZER INC.
May 17, 2018 $6,000 TALTZ Consulting ELI LILLY AND COMPANY
Apr 13, 2018 $6,000 No Listed Product Consulting UCB SA
Feb 9, 2018 $5,700 TALTZ Consulting LILLY USA, LLC
Sep 17, 2018 $5,000 XELJANZ Consulting PFIZER INC.
Sep 27, 2018 $5,000 XELJANZ Consulting PFIZER INC.
Sep 28, 2018 $4,543 COSENTYX Consulting NOVARTIS PHARMACEUTICALS CORPORATION

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/60322

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.